Peter P. Toth, Kevin Maki

Practical Lipid Management

Concepts and Controversies

• Gebundenes Buch

Produktbeschreibung

A practical text on the clinical management of dyslipidemias, Practical Lipid Management balances conceptual development and pathophysiology with a straightforward approach to the identification and treatment of abnormalities in lipid metabolism.

The book explores the role of novel risk markers in clinical practice, summarizes the current guidelines for lipid management, and offers a critical and systematic approach to interpreting the results of clinical trials. A feature of the book is a set of sidebars which explore current controversies and unanswered questions in clinical lipidology. The treatment of specific dyslipidemias is illustrated with case studies. Treatment algorithms are also provided.

Practical Lipid Management

_ details the relationship between specific lipids, lipoproteins and cardiovascular disease

_ provides guidance on the etiology and diagnosis of lipid abnormalities

_ summarizes current understanding of atherogenesis

_ reviews the evidence base for the use of therapeutic lifestyle change and specific lipid-lowering medications to reduce morbidity and mortality from cardiovascular disease

_ includes a cutting edge discussion of the controversies arising from the results of the ENHANCE (Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression) Trial

Practical Lipid Management provides a concise summary of best practice according to various international guidelines, making it a useful tool for all primary care physicians and others involved in the management of diseases such as diabetes, cardiovascular disease and stroke. It will serve as an evidence-based, rapid, and valuable resource for family physicians, internists, nurse practitioners, physician assistants, cardiologists, endocrinologists and allied health professionals involved in the care of patientswith lipid disorders.

Produktdetails

• Verlag: Wiley & Sons
• 1. Auflage
• Seitenzahl: 256
• Erscheinungstermin: 1. Dezember 2008
• Englisch
• Abmessung: 198mm x 130mm x 20mm
• Gewicht: 368g
• ISBN-13: 9780470056905
• ISBN-10: 0470056908
• Artikelnr.: 22925502

Autorenporträt

Peter P. Toth, M.D., Ph.D., FAAFP, FICA, FAHA, FACC. Director of Preventive Cardiology, Sterling Rock Falls Clinic, Ltd., Illinois, USA; Chief of Medicine, CGH Medical Center, Illinois, USA; Visiting Clinical Associate Professor, University of Illinois School of Medicine, USA; Editor-in-Chief, Journal of Applied Research?in Clinical and Experimental Therapeutics. Kevin C. Maki, PhD. President, Provident Clinical Research & Consulting, Inc., USA.

Inhaltsangabe

Foreword. Preface. Acknowledgements. Chapter 1 Epidemiology of Lipids,
Lipid Management and Risk for Coronary Heart Disease: An Overview.
Controversy: Should a Measure of Atherogenic Lipoprotein Particle Number be
used in Risk Assessment And/Or to Evaluate the Response to Lipid Therapy?
Chapter 2 Vascular Biology and Atherogenesis. Chapter 3 Detection,
Evaluation, and Treatment Goals for Lipid Disorders in Adults. Controversy:
Should Treatment Guidelines Include Targets for the Total/HDL Cholesterol
Ratio? Chapter 4 Therapeutic Lifestyle Changes in the Management of Lipid
Disorders and the Metabolic Syndrome. Chapter 5 Management of Elevated
Low-Density Lipoprotein Cholesterol. Controversy: How Low Should We Go?
Controversy: Risks and Benefits of High-Dose Statin Therapy Versus
Combination Lipid Drug Therapy. Controversy: Do the Benefits of Low-Density
Lipoprotein Cholesterol Reduction Depend Strictly on "How Low You Go" or
also on "How You Get There"? Chapter 6 Management of Elevated Triglycerides
and Non-High-Density Lipoprotein Cholesterol. Controversy: Do we Need a
Triglyceride Treatment Target to Insure a Predominance of Larger, More
Buoyant LDLParticles? Chapter 7 Management of Depressed High-Density
Lipoprotein Cholesterol. Controversy: Do we Need HDL Treatment Goals?
Chapter 8 Lipid Management in Population Subsets: Women, the Elderly,
Ethnic Minorities, Children, and Adolescents. Chapter 9 Emerging Risk
Factors and Biomarkers of Cardiovascular Disease. Chapter 10 A Primer on
Clinical Trials and Critical Review of Clinical Trial Reports for the
Clinician. Chapter 11 Case Studies. Index.

Rezensionen

"This is an essential book for physicians who manage patients with lipid disorders. There is no comparable book that provides the depth of information this one does while remaining practical in approach." ( Doody s , September 2009)